Haoxi Health Technology Limited (HAO)
USD 0.13
(-8.36%)
USD 0.13
(-8.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -747.57 Thousand | -872.13 Thousand | -675.36 Thousand | 2.64 Million |
| Net Income | 1.29 Million | 969.75 Thousand | 244.58 Thousand | 304.06 Thousand |
| Depreciation & Amortization | 10.56 Thousand | 8393.00 | 2212.00 | 411.00 |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -2.04 Million | -1.85 Million | -763.15 Thousand | 2.15 Million |
| Other non-cash items | - | -1.83 Million | -917.73 Thousand | 2.34 Million |
| Investing Cash Flow | -3.12 Million | -45.5 Thousand | -8698.00 | -3262.00 |
| Investments in PPE | -55.36 Thousand | -45.5 Thousand | -8698.00 | -3262.00 |
| Acquisitions | - | - | - | - |
| Investment purchases | -3.07 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -3.07 Million | - | - | - |
| Financing Cash Flow | 9.32 Million | 1.8 Million | 933.21 Thousand | -2.61 Million |
| Debt repayment | -362.47 Thousand | -387.86 Thousand | -769.29 Thousand | -2.61 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 8.97 Million | 1.41 Million | 163.92 Thousand | - |
| Other Financing Activities | -14.32 Thousand | -558.52 Thousand | 491.49 Thousand | -1.26 Million |
| Accounts receivables | -217.9 Thousand | -4279.00 | 665.61 Thousand | -295.26 Thousand |
| Accounts payables | 623.16 Thousand | -1.2 Million | -1.6 Million | 2.7 Million |
| Inventory | - | - | - | - |
| Other working capital | -2.45 Million | 1.39 Million | -369.22 Thousand | 430.14 Thousand |
| Cash at beginning of period | 1.2 Million | 293.51 Thousand | 55.88 Thousand | 20.33 Thousand |
| Cash at end of period | 6.65 Million | 1.2 Million | 293.51 Thousand | 55.88 Thousand |
| Capital Expenditure | -55.36 Thousand | -45.5 Thousand | -8698.00 | -3262.00 |
| Effect of forex changes on cash | 5601.00 | 24.75 Thousand | -15.59 Thousand | 2791.00 |
| Net cash flow / Change in cash | 5.45 Million | 909.69 Thousand | 237.62 Thousand | 35.55 Thousand |
| Free Cash Flow | -802.94 Thousand | -917.63 Thousand | -684.05 Thousand | 2.64 Million |
| Breakdown | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 531.46 Thousand | 380.09 Thousand | 380.09 Thousand | 969.75 Thousand | 261.35 Thousand | 261.35 Thousand |
| Depreciation & Amortization | - | 5792.00 | 5792.00 | 8393.00 | 3344.00 | 3344.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.57 Million | -1.03 Million | -1.03 Million | -1.85 Million | -1.58 Million | -1.58 Million |
| Other non-cash items | -1014.00 | 802.31 Thousand | 802.31 Thousand | -1.83 Million | 777.84 Thousand | 777.84 Thousand |
| Investing Cash Flow | -3.11 Million | -8081.00 | -8081.00 | -45.5 Thousand | -20.93 Thousand | -20.93 Thousand |
| Investments in PPE | -39.2 Thousand | -8081.00 | -8081.00 | -45.5 Thousand | -20.93 Thousand | -20.93 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.07 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 9.08 Million | 119.69 Thousand | 119.69 Thousand | 1.8 Million | -76.5 Thousand | -76.5 Thousand |
| Debt repayment | -89.48 Thousand | -258.66 Thousand | - | -387.86 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.99 Million | -19.26 Thousand | - | 1.41 Million | - | - |
| Other Financing Activities | - | 119.69 Thousand | 119.69 Thousand | -558.52 Thousand | -76.5 Thousand | -76.5 Thousand |
| Accounts receivables | -9547.00 | -104.17 Thousand | -104.17 Thousand | -4279.00 | -3355.00 | -3355.00 |
| Accounts payables | -340.51 Thousand | 963.68 Thousand | - | -1.2 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.22 Million | -933.52 Thousand | -933.52 Thousand | 1.39 Million | -1.57 Million | -1.57 Million |
| Cash at beginning of period | 1.11 Million | 588.4 Thousand | - | 293.51 Thousand | - | 2.44 Million |
| Cash at end of period | 6.65 Million | 1.11 Million | -45.28 Thousand | 1.2 Million | -622.38 Thousand | 1.82 Million |
| Capital Expenditure | -39.2 Thousand | -8081.00 | -8081.00 | -45.5 Thousand | -20.93 Thousand | -20.93 Thousand |
| Effect of forex changes on cash | - | -307.4 Thousand | -307.4 Thousand | 24.75 Thousand | 13.64 Thousand | 13.64 Thousand |
| Net cash flow / Change in cash | 5.54 Million | 524.23 Thousand | -45.28 Thousand | 909.69 Thousand | -622.38 Thousand | -622.38 Thousand |
| Free Cash Flow | -1.08 Million | 142.41 Thousand | 142.41 Thousand | -917.63 Thousand | -559.52 Thousand | -559.52 Thousand |
300913
MFCO
MRKV
HFCL
TRFE
SHRIRAMFIN